Sanofi
SNY
SNY
478 hedge funds and large institutions have $7.6B invested in Sanofi in 2018 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 133 increasing their positions, 181 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
478
Holders Change
-8
Holders Change %
-1.65%
% of All Funds
10.96%
Holding in Top 10
10
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+42.86%
% of All Funds
0.23%
New
53
Increased
133
Reduced
181
Closed
55
Calls
$51.2M
Puts
$11.5M
Net Calls
+$39.8M
Net Calls Change
+$4.54M
Top Buyers
| 1 |
Fisher Asset Management
Camas,
Washington
|
+$22M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$14.7M |
| 3 |
HCM
Hamlin Capital Management
New York
|
+$11.8M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$9.92M |
| 5 |
Barclays
London,
United Kingdom
|
+$8.19M |
Top Sellers
| 1 |
Franklin Resources
San Mateo,
California
|
-$724M |
| 2 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
-$86.1M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$63.2M |
| 4 |
Morgan Stanley
New York
|
-$51.5M |
| 5 |
SAM
Senzar Asset Management
New York
|
-$17.4M |
